Stephens Lowers Rating on TECH to Hold
Stephens downgraded TECH to a hold with a $73 price target, a 3.25% upside from the current price.
Key Points
- Stephens downgraded TECH to a hold rating on June 26, 2026, setting a price target at $73 as the stock traded near $70.70.
- Stephens's $73 price target implies 3.25% upside from Bio-Techne Corporation's ($TECH) current $70.70 share price.
- Shares of TECH saw institutional activity with BlackRock and Morgan Stanley increasing their holdings, while FMR LLC significantly boosted its position.
- Insider activity included sales and buys by executives, with Amy Herr purchasing and selling shares on May 8, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 26, 2026, Stephens lowered its rating on TECH to a hold, setting a price target of $73. This downgrade came as TECH's shares were trading around $70.70 on Friday.
Stephens & Co. vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in TECH
Institutional investors have been actively trading TECH. BlackRock, Inc. increased its holdings by 135,388 shares, bringing its total to 12,264,513 shares valued at approximately $640.9 million, marking a 1.1% increase. Morgan Stanley also added to its position, with an increase of 187,459 shares, ending with 8,532,873 shares worth about $445.9 million, reflecting a 2.2% rise. FMR LLC made a significant move by increasing its stake by 6,884,967 shares, resulting in a total of 7,899,928 shares valued at $412.9 million, a substantial 678.3% increase. Meanwhile, Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both opened new positions with 10,179,709 and 6,480,337 shares respectively.
Insider Buying and Selling at Bio-Techne Corporation
Insider activity at TECH has been notable. On June 2, 2026, Steven Crouse, President of Diagnostics & Spatial Biology, sold 600 shares and also bought 600 shares on the same day. On May 8, 2026, Amy Herr purchased 6,636 shares at $47.60 and later sold the same amount at prices of $47.60 and $48.28.
Analysts Set New Price Targets
On June 26, 2026, Stephens & Co. downgraded TECH to a hold rating, setting a price target of $73. On the same day, Baird maintained its hold rating with the same target price. Earlier, on June 11, 2026, Piper Sandler initiated coverage with a hold rating and a $65 target. RBC Capital reinstated a buy rating with a $62 target on May 15, 2026. Citigroup and Wells Fargo both maintained buy ratings with target prices of $70 and $62, respectively, in early May.
Bottom Line
Stephens' decision to lower its rating on TECH to hold with a $73 target highlights a cautious stance on the stock's outlook. Institutional investors have shown varied interest, with some increasing their stakes significantly, while others are just initiating positions. Insider transactions reveal ongoing activity among executives, and analysts continue to provide mixed ratings, reflecting uncertainty in the market. As always, these ratings are backward-looking and may not reflect the current market sentiment.
Get Bio-Techne Corporation alerts
New 13F filings, insider trades, and analyst moves on $TECH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.